Renaissance Technologies
AXDX

Renaissance Technologies’s Accelerate Diagnostics AXDX Stock Holding History

Renaissance Technologies’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-64,200
Closed -$45K – 3549
2025
Q1 		$45K Sell
64,200
-42,862
-40% -$48.8K ﹤0.01% 3298
2024
Q4 		$128K Buy
107,062
+65,984
+161% +$110K ﹤0.01% 3246
2024
Q3 		$70.2K Buy
+41,078
New +$60.9K ﹤0.01% 3309
2021
Q2 		– Sell
-7,960
Closed -$662K – 3446
2021
Q1 		$662K Sell
7,960
-10,588
-57% -$1.07M ﹤0.01% 2797
2020
Q4 		$1.41M Buy
18,548
+10,868
+142% +$973K ﹤0.01% 2325
2020
Q3 		$819K Buy
+7,680
New +$1.07M ﹤0.01% 2607
2017
Q3 		– Sell
-989
Closed -$270K – 3197
2017
Q2 		$270K Buy
+989
New +$268K ﹤0.01% 2927
2016
Q2 		– Sell
-7,089
Closed -$1.02M – 3322
2016
Q1 		$1.02M Buy
+7,089
New +$1M ﹤0.01% 2583

Other funds holding AXDX

BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
BCWM
Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Renaissance Technologies's AXDX Position: Q2 2025 in Review

Renaissance Technologies sold out of Accelerate Diagnostics (AXDX) in Q2 2025, closing a stake of 64,200 shares — an estimated $45K sold.

Renaissance Technologies first reported a position in AXDX in Q1 2016 and held it in 8 quarters. The position peaked at $1.41M in Q4 2020. 3 funds tracked by Wall St. Rank hold AXDX as of Q2 2025.

  • Renaissance Technologies reported no remaining Accelerate Diagnostics position as of Q2 2025 after selling out during the quarter.
  • Renaissance Technologies sold 64,200 Accelerate Diagnostics shares in Q2 2025, an estimated $45K.
  • Renaissance Technologies first reported a position in Accelerate Diagnostics in Q1 2016 and held it in 8 quarters.
  • Renaissance Technologies's Accelerate Diagnostics position peaked at $1.41M in Q4 2020.
  • 3 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2025.

Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.